BRPI1009132A2 - derivados de rosuvastatina e atorvastatina - Google Patents

derivados de rosuvastatina e atorvastatina

Info

Publication number
BRPI1009132A2
BRPI1009132A2 BRPI1009132A BRPI1009132A BRPI1009132A2 BR PI1009132 A2 BRPI1009132 A2 BR PI1009132A2 BR PI1009132 A BRPI1009132 A BR PI1009132A BR PI1009132 A BRPI1009132 A BR PI1009132A BR PI1009132 A2 BRPI1009132 A2 BR PI1009132A2
Authority
BR
Brazil
Prior art keywords
rosuvastatin
atorvastatin
derivatives
atorvastatin derivatives
Prior art date
Application number
BRPI1009132A
Other languages
English (en)
Inventor
Derek Lindsay
Inder Bhamra
Peter Jackson
Stephen Hindley
Original Assignee
Redx Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Redx Pharma Ltd filed Critical Redx Pharma Ltd
Publication of BRPI1009132A2 publication Critical patent/BRPI1009132A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
BRPI1009132A 2009-03-10 2010-03-10 derivados de rosuvastatina e atorvastatina BRPI1009132A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0904104.7A GB0904104D0 (en) 2009-03-10 2009-03-10 Atorvastatin and rosuvastatin derivatives
PCT/GB2010/050407 WO2010103318A1 (en) 2009-03-10 2010-03-10 Rosuvastatin and atorvastatin derivatives

Publications (1)

Publication Number Publication Date
BRPI1009132A2 true BRPI1009132A2 (pt) 2016-03-01

Family

ID=40600805

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1009132A BRPI1009132A2 (pt) 2009-03-10 2010-03-10 derivados de rosuvastatina e atorvastatina

Country Status (20)

Country Link
US (2) US8513412B2 (pt)
EP (2) EP2405910B1 (pt)
JP (1) JP5765738B2 (pt)
KR (1) KR20110126164A (pt)
CN (2) CN102387800B (pt)
AU (1) AU2010222656B2 (pt)
BR (1) BRPI1009132A2 (pt)
CA (1) CA2754562A1 (pt)
DK (1) DK2405910T3 (pt)
EA (1) EA020591B1 (pt)
ES (1) ES2435643T3 (pt)
GB (1) GB0904104D0 (pt)
IL (1) IL215040A (pt)
MX (1) MX2011009458A (pt)
NZ (1) NZ595113A (pt)
PL (1) PL2405910T3 (pt)
PT (1) PT2405910E (pt)
SG (1) SG174303A1 (pt)
WO (1) WO2010103318A1 (pt)
ZA (1) ZA201107051B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0904102D0 (en) * 2009-03-10 2009-04-22 Bradford Pharma Ltd Use of atorvastatin lactols as medicaments
GB0904100D0 (en) * 2009-03-10 2009-04-22 Bradford Pharma Ltd Use of rosuvastatin lactols as medicaments
US9353061B2 (en) * 2012-07-20 2016-05-31 Academia Sinica 3,5,N-trihydroxy-alkanamide and derivatives: method for making same and use thereof
CN103724278B (zh) * 2013-12-12 2019-03-29 江苏阿尔法药业有限公司 他汀类中间体及其衍生物的制备方法
US20180153993A1 (en) * 2016-12-07 2018-06-07 The Chinese University Of Hong Kong Compositions and methods for treatment and prevention of cardiovascular diseases
JP7010137B2 (ja) 2017-09-26 2022-01-26 日本精工株式会社 単列深溝玉軸受の製造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681893A (en) 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
ATE132496T1 (de) * 1987-07-10 1996-01-15 Hoechst Ag 3-desmethyl-mevalonsäurederivate, verfahren zu ihrer herstellung, pharmazeutische präparate auf basis dieser verbindungen, ihre verwendung sowie zwischenprodukte
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
JP2648897B2 (ja) 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
GB0317393D0 (en) * 2003-07-25 2003-08-27 Avecia Ltd Process and compounds
BRPI0412786A (pt) * 2003-07-25 2006-09-26 Avecia Pharmaceuticals Ltd processo para a preparação de um composto, e, composto
GB0406757D0 (en) * 2004-03-26 2004-04-28 Avecia Ltd Process and compounds
DE102005022284A1 (de) * 2005-05-13 2006-11-23 Ratiopharm Gmbh Verfahren zur Herstellung von Statinen
EP1834944A1 (en) * 2006-03-17 2007-09-19 Ratiopharm GmbH Process for preparing C7 intermediates and their use in the preparation on N-substituted pyrrole derivatives
CN101376647B (zh) * 2007-08-31 2010-12-08 中山奕安泰医药科技有限公司 一种用于合成瑞舒伐他汀中间体及瑞舒伐他汀的合成方法
GB0904102D0 (en) 2009-03-10 2009-04-22 Bradford Pharma Ltd Use of atorvastatin lactols as medicaments
GB0904100D0 (en) * 2009-03-10 2009-04-22 Bradford Pharma Ltd Use of rosuvastatin lactols as medicaments

Also Published As

Publication number Publication date
EP2614822A3 (en) 2013-07-24
ES2435643T3 (es) 2013-12-20
MX2011009458A (es) 2012-03-14
WO2010103318A1 (en) 2010-09-16
US20130303773A1 (en) 2013-11-14
SG174303A1 (en) 2011-10-28
EP2614822B1 (en) 2014-12-24
US8513412B2 (en) 2013-08-20
CN103224490A (zh) 2013-07-31
CN102387800B (zh) 2013-11-27
EP2614822A2 (en) 2013-07-17
CN102387800A (zh) 2012-03-21
US9006282B2 (en) 2015-04-14
PL2405910T3 (pl) 2014-01-31
KR20110126164A (ko) 2011-11-22
DK2405910T3 (da) 2013-12-02
PT2405910E (pt) 2013-11-26
IL215040A0 (en) 2011-11-30
EP2405910A1 (en) 2012-01-18
AU2010222656B2 (en) 2014-09-18
EA201101195A1 (ru) 2012-04-30
GB0904104D0 (en) 2009-04-22
IL215040A (en) 2014-12-31
CA2754562A1 (en) 2010-09-16
ZA201107051B (en) 2014-03-26
JP2012520279A (ja) 2012-09-06
EP2405910B1 (en) 2013-09-04
JP5765738B2 (ja) 2015-08-19
US20110319617A1 (en) 2011-12-29
AU2010222656A1 (en) 2011-09-29
EA020591B1 (ru) 2014-12-30
NZ595113A (en) 2013-02-22

Similar Documents

Publication Publication Date Title
NL350111I2 (nl) fenpicoxamid en prothioconazool
BR112012003709A2 (pt) compostos heterocíclicos e usos dos mesmos
BRPI1013246A2 (pt) derivados de benzofuralina
BR112012002828A2 (pt) derivados de 5-fluorpirimidinona
BRPI0907231A2 (pt) pirrolpirimidinas e pirrolpiridinas
BRPI0907435A2 (pt) Derivados de 5-flúor pirimidina
BRPI0908906A2 (pt) compostos heterocíclicos e usos dos mesmos
DOP2011000288A (es) Fusiones y conjugados de farmaco
BR112012010242A2 (pt) derivados de heteroarilpiperidina e heteroarilpiperazina
BRPI0920927A2 (pt) derivados de azaquinolinona e usos dos mesmos
BRPI0914544A2 (pt) derivados de pirimidona substituídos
BR112012001260A2 (pt) conjugados de epsilon-polilisina e o emprego dos mesmos
BRPI1013844A2 (pt) derivados de piridina-isoxazol
BRPI1016117A8 (pt) derivados de isoxazol-isoxazol e isoxazol-isotiazol.
BRPI0913832A2 (pt) derivados de pirrolopiridinilpirimidin-2-ilamina
BRPI0915064A2 (pt) derivados de qunoxalinadiona
BRPI1010024A2 (pt) derivados de aminopirrolidinona e uso dos mesmos
DK2397480T3 (da) Diazepindionderivat
BRPI1008752A2 (pt) compostos alquilamido e usos dos mesmos
BRPI1014454A2 (pt) derivados de isoxazol-pirazol
DK2387580T3 (da) Deoxyactagardinderivater
BRPI0913234A2 (pt) derivados de tiazolilpiperidina
BR112012002810A2 (pt) derivados de n1-acil-5-fluoropirimidinona
BRPI0922652A2 (pt) Derivados de quinazolinamida
BRPI1009132A2 (pt) derivados de rosuvastatina e atorvastatina

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: REDX PHARMA PLC (GB)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]